Login
Toggle navigation
Videos
Categories
Trending
Dr. Darrell Kohli - Residency at Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Residents describe their training experience at Mayo Clinic's Department of Ophthalmol
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Tyro CEO Robbie Cooke Featured as Stock of the Day | Robbie Cooke, CEO, Tyro Payments Ltd.
00:10:00
Kimberly Ann discusses Lahontan Gold Corp.'s exploration projects in Nevada, including updates on drilling results, permitting processes, and plans for bringing the Santa Fe Mine back into production.|Kimberly Ann, Founder, CEO, President, and Director of
00:10:00
Unicorn Rising: dLocal CEO Sebastián Kanovich on Uruguay's Milestone | Sebastián Kanovich - CEO of dLocal
00:10:00
Peninsula Energy: Leading U.S. Uranium Producer with Strong Growth Potential
00:10:00
Khairussaleh Ramli's Strategy for Maybank's Future | Khairussaleh Ramli, CEO, Maybank .
00:10:00
Navigating ESOP Transactions: The Importance of Managerial Support and Data Management
00:10:00
From Corporate Success to Spiritual Calling: The Journey of Tom Ferguson | Thomas E Ferguson - CEO of AZZ Incorporated
00:10:00
Fireside Chat with David Foulkes: Brunswick CEO at The Boat Show | David M. Foulkes - CEO of Brunswick Corp
00:10:00
Exploring Gold Potential in Brazil: Cabral Gold's Path to Growth
00:10:00
Iran's Nuclear Ambitions and Regional Strategy: An Analysis by Victor Davis Hanson and Robert Baer|
00:10:00
Two IRA Mistakes Every Investor Should Avoid | Mike Palmer, Managing Principal , Ark Royal Wealth Management.
00:10:00
Private Equity in Sri Lanka: Opportunities for Growth and Investment Insights from Zephyr Management's Thomas Barry